Anti-Viral Prophylaxis Target Product Profile Guidelines

Abstract

The Transformational Medical Technologies Initiative (TMTI) program was given broad guidance through the current Initial Capabilities Documents (ICDs) to develop broad-spectrum medical therapeutics to mitigate the negative operational impact of a biological attack. The therapeutic must be safe and effective, easy to use, and cause minimal side-effects. This Target Product Profile (TPP) guideline describes drug candidates or passive immune products to be used as prophylaxis to prevent disease due to viral pathogens. This Target Product Profile does not pertain to vaccine development. The prophylaxis candidates will be used to prophylax patients who have been exposed to the pathogen, and are asymptomatic.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Feb 24, 2009
Accession Number
ADA514791

Entities

Organizations

  • Office Of The Under Secretary Of Defense

Tags

DTIC Thesaurus Topics

  • Department Of Defense
  • Diseases And Disorders
  • Health
  • Health Services
  • Hepatitis
  • Immune Serums
  • Immunoglobulins
  • Medical Countermeasures
  • Pathogenic Bacteria
  • Preventive Medicine
  • Program Management
  • Public Health
  • Serum Globulin
  • Side Effects
  • Standards
  • Therapy
  • Virus Diseases

Fields of Study

  • Medicine
  • Physics

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Oncology
  • Software Engineering

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech